Basler Kantonalbank Share Price

Certificat

BIPBKB

CH1261613066

Market Closed - Swiss Exchange 08:50:00 27/05/2024 pm IST
102 CHF +0.07% Intraday chart for Basler Kantonalbank
6 months+0.75%
Current year-0.77%
Date Price Change
27/24/27 102 +0.07%

Delayed Quote Swiss Exchange

Last update May 27, 2024 at 08:50 pm IST

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Basler Kantonalbank
BIPBKB
ISINCH1261613066
Date issued 11/10/2023
Strike 89.68 CHF
Maturity 13/10/2025 (499 Days)
Parity 0.02 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 103.4 CHF
Lowest since issue 97 CHF
Spread 41 CHF
Spread %0.80%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
103.1 USD
Average target price
108.8 USD
Spread / Average Target
+5.53%
Consensus
  1. Stock Market
  2. Certificates
  3. BIPBKB Certificat